Study factors associated with poor glycemic control in type 2 diabetes mellitus patients in tertiary care center

Anita Mathuriya; Shahid Abbas

doi:10.18203/2320-6012.ijrms20231606

Authors

Anita Mathuriya Department of General Medicine, Sri Aurobindo Medical College and Postgraduate Institute, Indore, Madhya Pradesh, India
Shahid Abbas Department of General Medicine, Sri Aurobindo Medical College and Postgraduate Institute, Indore, Madhya Pradesh, India

DOI:

https://doi.org/10.18203/2320-6012.ijrms20231606

Keywords:

Co-morbidity, Glycemic control, Type 2 diabetes

Abstract

Background: Poor glycemic control is a major public health issue among patients with type 2 diabetes mellitus and a significant risk factor for the progression of diabetic complications. This study aimed to assess the magnitude and contributing factors of poor glycemic control among type 2 diabetes patients.

Methods: A cross-sectional study was conducted among 150 type 2 diabetes patients a sample of 150 type 2 diabetics of both sexes was obtained diabetes in medicine OPD, any type 2 diabetes patient at the healthcare facilities over the age of 18 was eligible to participate in the study.

Results: Of the 150 type 2 diabetes patients included in the study, 118 had poor glycemic control. Mean age was 59.67 (SD = 9.617) years; 115 (76.9%) of them were men. Most patients [n = 62 (41%)] used insulin or oral anti-diabetics as monotherapy [n = 32 (21%)] to regulate their blood sugar levels. The glycemic control got worse the longer the patient had diabetes, from 5 to 10 years (OR = 1.74) to more than 10 years (OR = 2.55), compared to patients with less than 5 years of illness. In comparison to patients with co-morbidity, patients without co-morbidity had significantly better glycemic control (OR=1.56).

Conclusions: Gender, age, BMI, occupation, medical history, medication history, triglycerides, HDL, duration of diabetes, type and number of diabetes medications, and HbA1c were significantly associated. These factors can identify patients at risk of poor glycemic control, allowing targeted interventions for optimal outcomes. Adherence, physical activity, diabetes education, and training affect glycemic control, but this study did not.

Metrics

Metrics Loading ...

References

International Diabetes Federation. Diabetes and cardiovascular disease. Brussels: International Diabetes Federation; 2016. Available at: https://issuu.com/int._diabetes_federation/docs/cvd_in_diabetes_report-2016. Accessed 20 January 2023.

Fowler MJ. Microvascular and Macrovascular Complications of Diabetes. Clin Diab. 2008;26:77–82.

Turner R, Holman R, Cull C. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet. 1998;352:837–53.

Diabetes complication control Trial group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med. 1993;329:977–86.

Kelly N, Bazzano A, Fonseca A, Thethi K, Reynolds K, Jiang H. Glucose control and cardiovascular disease in type-2 diabetes: a meta-analysis. Ann Intern Med. 2010;152(1):63-4.

Mohan V, Seedat YK, Pradeepa R. The Rising Burden of Diabetes and Hypertension inSoutheast Asian and African Regions: Need for effective strategies for Prevention and Control in Primary Health Care Settings. Int J Hypertens. 2013;2013:409083.

Rathmann W, Giani G. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27(10):2568-9.

Rahelić D. OF IDF diabetes atlas-call for immediate action. Lijĕ cnĭ cki vjesnik. 2016;138(1-2):57.

Aspray TJ, Mugusi F, Rashid S, Whiting D, Edwards R, Alberti KG, et al. Rural and urban differences in diabetes prevalence in Tanzania: the role of obesity, physical inactivity, and urban living. Trans R Soc Trop Med Hyg. 2000;94 (6):637-44.

Edwards R, Unwin N, Mugusi F, Whiting D, Rashid S, Kissima J, et al. Hypertension prevalence and care in an urban and rural area of Tanzania. J Hypertens. 2000;18(2):145-52.

Misganaw A, Mariam DH, Araya T. The double mortality burden among adults in Addis Ababa, Ethiopia, 2006-2009. Prev Chronic Dis. 2012;9:E84.

Eckel RH, Kahn SE, Ferrannini E, Goldfine AB, Nathan DM, Schwartz MW, et al. Obesity and type 2 diabetes: what can be unified and what needs to be individualized? J Clin Endocrinol Metab. 2011;96(6):1654-63.

Hardy OT, Czech MP, Corvera S. What causes the insulin resistance underlying obesity? Curr Opin Endocrinol Diabetes Obes. 2012;19 (2):81-7.

Zoungas S, Chalmers J, Ninomiya T, Li Q, Cooper M, Colagiuri S, et al. Association of HbA1c levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholds. Diabetologia. 2012;55:636-43.

Davies M. The reality of glycaemic control in insulin-treated diabetes: defining the clinical challenges. Int J Obes. 2004;28 (S2):S14.

Chan JC, Gagliardino JJ, Baik SH, Chantelot J-M, Ferreira SR, Hancu N, et al. Multifaceted determinants for achieving glycemic control. Diabetes Care. 2009;32(2):227-33.

Ahmad NS, Islahudin F, Paraidathathu T. Factors associated with good glycemic control among patients with type 2 diabetes mellitus. J Diabetes Invest. 2014;5:563-9.

Eticha T, AbrahaleyMulu HG, GetuKahsay DA, Rajeshwar Y. Factors associated with poor glycemic control in type 2 diabetic patients investigated at Ayder referral hospital, Mekelle, Ethiopia Ijppr. Human. 2016;6(3):160-71.

Mullugeta Y, Chawla R, Kebede T, Worku Y. Dyslipidemia associated with a poor glycemic control in type 2 diabetes mellitus and the protective effect of metformin supplementation. Indian J Clin Biochem. 2012;27(4):363-9.

Kassahun T, Eshetie T, Gesesew H. Factors associated with glycemic control among adult patients with type 2 diabetes mellitus: a cross-sectional survey in Ethiopia. BMC research notes. 2016;9(1):78.

Woldu M, Wami C, Lenjisa J, Tegegne G, Tesafye G, Dinsa H. Factors associated with poor glycemic control among patients with type 2 diabetes mellitus in ambo hospital. Ambo; Ethiopia Endocrinol Metab Synd. 2014;3(143):2161-1017.

Jeffcoate SL. Diabetes control and complications: the role of glycated haemoglobin, 25 years on. Diabetic Med. 2004;21(7):657-65.

Brown AF, Mangione CM, Saliba D, Sarkisian CA; California Healthcare Foundation/American Geriatrics Society Panel on Improving Care for Elders with Diabetes. Guidelines for Improving the Care of the Older Person with Diabetes Mellitus. J Am Geriatr Soc. 2003;51(5 Suppl Guidelines):S265-80.

American Diabetes Association. Standards of medical care in diabetes. Diab Care. 2014;37(Suppl 1):S14-80.

Monnier L, Colette C. Target for Glycemic Control Concentrating on glucose. Diabetes Care. 2009;32(Suppl 2):S199-204.

Canadian Diabetes Association Clinical Practice Guidelines Expert Committee, Imran SA, Rabasa-Lhoret R, Ross S. Targets for Glycemic Control. Can J Diab. 2013;37(Suppl 1):S31-4.

Qaseem A, Vijan S, Snow V, Cross JT, Weiss KB, Owens DK, et al. Glycemic control and type 2 diabetes mellitus: the optimal hemoglobin A1c targets. A Guidance Statement from the American College of Physicians. Ann Intern Med 2007;147(6):417-22.

Roy S, Sherman A, Monari-Sparks MJ, Schweiker O, Jain N, Sims E, et al. Association of comorbid and metabolic factors with optimal control of type 2 diabetes mellitus. N Am JMed Sci. 2016;8(1):31-9.

Huang ES, Liu JY, Moffet HH, John PM, Karter AJ. Glycemic control, complications, and death in older diabetic patients: the diabetes and aging study. Diabetes care. 2011;34(6):1329-36.

Woldu MA, Wami CD, Lenjisa JL, Tegegne G, Tesafye G, Dinsa H, et al. Factors associated with poor glycemic control among patients with type 2 diabetes mellitus in Ambo hospital, Ambo; Ethiopia. Endocrinol Metab Syndr. 2014;3(143):2161-1017.

Lee DC, Park I, Jun TW, Nam BH, Cho SI, Blair SN, et al. Physical activity and body mass index and their associations with the development of type 2 diabetes in Korean Men. Am J Epidemiol 2012;176(1):43-51.

Kassahun T, Eshetie T, Gesesew H. Factors associated with glycemic control among adult patients with type 2 diabetes mellitus: a cross- sectional survey in Ethiopia. BMC Res Notes 2016;9(1):78.

Khattab M, Khader YS, Al-Khawaldeh A, et al. Factors associated with poor glycemic control among patients with type 2 diabetes. J Diabetes Complications. 2010;24(2):84-9.

Salonen JT, Lakka TA, Lakka HM, Valkonen VP, Everson SA, Kaplan GA. Hyperinsulinemia is associated with the incidence of hypertension and dyslipidemia in middle-aged men. Diabetes. 1998;47(2):270-5.

Agarwal AA, Jadhav PR, Deshmukh YA. Prescribing pattern and efficacy of anti-diabetic drugs in maintaining optimal glycemic levels in diabetic patients. J Basic Clin Pharm. 2014;5(3):79-83.

Esposito K, Chiodini P, Bellastella G, Maiorino MI, Giugliano D. Proportion of patients at HbA1c target <7% with eight classes of antidiabetic drugs in type 2 diabetes: systematic review of 218 randomized controlled trials with 78 945 patients. Diabetes Obes Metab. 2012;14(3):228-33.

Schweizer A, Couturier A, Foley JE, Dejager S. Comparison between vildagliptin and metformin to sustain reductions in HbA1c over 1 year in drug-naïve patients with Type 2 diabetes. Diabet Med. 2007;24(9):955-61.

Juarez DT, Sentell T, Tokumaru S, Goo R, Davis JW, Mau MM. Factors associated with poor glycemic control or wide glycemic variability among diabetes patients in Hawaii, 2006–2009. Prev Chronic Dis. 2006;2009(9):1-0.

Kirk JK, Davis SW, Hildebrandt CA, Strachan EN, Peechara ML, Lord R. Characteristics associated with glycemic control among family medicine patients with type 2 diabetes. N C Med J 2011;72(5):345-50.

Zhao W, Katzmarzyk PT, Horswell R, Wang Y, Johnson J, Hu G. Sex differences in the risk of stroke and HbA1c among diabetic patients. Diabetologia. 2014;57(5):918-26.

Harrabi I, Al Harbi F, Al Ghamdi S. Predictors of Glycemic Control among Patients with Type 2 Diabetes in Najran Armed Forces Hospital: A Pilot Study. J Diabetes Mellitus. 2014;40(2):141-7.

Eid M, Mafauzy M, Faridah A. Glycaemic Control of Type 2 Diabetic Patients on Follow Up at Hospital UniversitiSains Malaysia. Malays J Med Sci. 2003;10(2):40-9.

Adham M, Froelicher ES, Batieha A, Ajlouni K. Glycaemic control and its associated factors in type 2 diabetic patients in Amman, Jordan. East Mediterr Health J. 2010;16(7):732-9.

Bays HE, Chapman RH, Grandy S, the SHIELD Investigators’ Group. The relationship of body mass index to diabetes mellitus, hypertension and dyslipidaemia: comparison of data from two national surveys. Int J Clin Pract. 2007;61(5):737-47.

Papazafiropoulou A, Sotiropoulos A, Skliros E, Kardara M, Kokolaki A, Apostolou O, et al. Familial history of diabetes and clinical characteristics in Greek subjects with type 2 diabetes. BMC Endocr Disord 2009;9(1):12.

Bo S, Cavallo‐Perin P, Gentile L, Repetti E, Pagano G. Influence of a familial history of diabetes on the clinical characteristics of patients with Type 2 diabetes mellitus. Diabet Med. 2000;17(7):538-42.

Benoit SR, Fleming R, Philis-Tsimikas A, Ji M. Predictors of glycemic control among patients with Type 2 diabetes: A longitudinal study. BMC Public Health 2005;5:36.

El-Kebbi IM, Ziemer DC, Cook CB, Miller CD, Gallina DL, Phillips LS. Comorbidity and glycemic control in patients with type 2 diabetes. Arch Intern Med. 2001;161(10):1295-300.